It won't be available until next flu season, so health officials urge you and your children make an appointment with a clinic ...

The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis ...

Whether it’s allergies, a sinus infection or runny nose, many people turn to nasal sprays for quick relief. Now, there’s growing interest in other nasal spray products, such as vaccines, and even life ...

FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.

For years nasal sprays have helped people with allergies. Recently, treating migraines, depression and opioid overdoses joined the list. There’s even an intranasal option for the flu vaccine. Doctors ...

With Cold Weather quickly approaching, The Food and Drug Administration finally approved FluMist to be used at Home.

There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...

The vaccine, called FluMist, is a nasal vaccine that's been available since 2003 but given in-clinic by a healthcare provider ...

The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...

The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...